G. Hedelin

TL;DR: EUROCARE-3 as mentioned in this paper analyzed the survival of 1815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries and found that survival was highest in northern Europe (Sweden, Norway, Finland and Iceland), and fairly good in central-southern Europe (France, Switzerland, Austria and Spain).

TL;DR: A striking divergence between incidence and mortality trends is observed for a great number of cancers, and prostate cancer shares with breast cancer the same pattern of a severe increasing incidence and a stable mortality.

TL;DR: In this paper, the authors provided updated estimates of national trends in cancer incidence and mortality for France for 1980-2005 for 25 cancer sites and found that the number of new cancer cases in 2005 was approximately 320,000, which corresponds to an 89% increase since 1980.

TL;DR: The divergence of cancer incidence and mortality trends in France over the 1980-2005 period can be explained by the combined effects of a decrease in the incidence of the most aggressive cancers and an increase in the occurrence of less aggressive cancers, partly due to changes in medical practices leading to earlier diagnoses.

TL;DR: Breast carcinoma survival rates were found to be higher in the U.S. than in Europe.